Saphris Prices, Coupons, Copay Cards & Patient Assistance
Saphris (asenapine) is a member of the atypical antipsychotics drug class and is commonly used for Bipolar Disorder, and Schizophrenia.
A generic version of Saphris is available. See asenapine prices.
Saphris prices
Sublingual Tablet
2.5 mg Saphris sublingual tablet from $1,355.98 for 60 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 60 (6 x 10 each) | $22.60 | $1,355.98 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
5 mg Saphris sublingual tablet from $1,355.98 for 60 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 60 (6 x 10 each) | $22.60 | $1,355.98 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
10 mg Saphris sublingual tablet from $1,355.98 for 60 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 60 (6 x 10 each) | $22.60 | $1,355.98 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Saphris Coupons, Copay Cards and Rebates
Saphris offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
No manufacturer promotions could be found for this medication.
Patient Assistance & Copay Programs for Saphris
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Saphris (asenapine maleate) Tablet; Sublingual
More information please phone: 800-675-8416 Visit website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Saphris (asenapine maleate) Tablet; Sublingual
More information please phone: 866-316-7263 Visit website
Provider: myAbbVie Assist Patient Assistance Program
Eligibility requirements:- Must be uninsured or underinsured
- At or below 400% of FPL
- Not applicable
- Must be a US resident and treated by a US licensed healthcare provider
- Any patient who requires the medication and are in need should call the company. Eligibility determined on a case-by-case basis. Patients with prescription drug coverage may be eligible on exception basis. Contact program for details.
- Saphris (asenapine maleate) Tablet; Sublingual
More information please phone: 800-222-6885 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Vraylar
Vraylar is a once a day antipsychotic medication used to treat mental health or mood disorders ...
Abilify
Abilify (aripiprazole) is an antipsychotic medication used to treat schizophrenia, bipolar I ...
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Seroquel
Seroquel is used to treat the symptoms of schizophrenia, bipolar disorder and major depressive ...
Zyprexa
Zyprexa (olanzapine) is an atypical antipsychotic that may be used to treat adults and adolescents ...
Latuda
Latuda information from Drugs.com, includes Latuda side effects, interactions and indications.
Rexulti
Rexulti is an antipsychotic used to treat major depressive disorder, schizophrenia, or agitation ...
Lurasidone
Lurasidone is used for bipolar disorder, borderline personality disorder, schizoaffective disorder ...
Risperidone
Risperidone is used to treat schizophrenia and symptoms of bipolar disorder. Learn about side ...
Olanzapine
Olanzapine (brand name Zyprexa) is an atypical antipsychotic that may be used to treat adults and ...
More about Saphris (asenapine)
- Check interactions
- Compare alternatives
- Reviews (319)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
- En español